
The Business Model by Inc.
Are Peptides a Miracle Elixir or a Dangerous Fad? | 1 Smart Business Story
The peptide craze has taken hold with entrepreneurs and executives hoping to further optimize their performance in all aspects of life — and maybe live forever, while they’re at it. Their interest in peptides is more than personal, though. Many founders see tremendous opportunity in startups focused on getting peptides into the mainstream and even corporate wellness packages. Meanwhile, many of the drugs are caught in a regulatory gray area that peptide pushers hope Robert F. Kennedy Jr., the secretary of Health and Human Services, can clear up. Inc. senior writer Sam Blum dove into the brave new world of peptides and joined 1 Smart Business Story host Ali Donaldson to share his findings. In this episode, you’ll learn: Why more founders love peptides, And why they see dollar signs in what’s now a gray-area marketplace. Plus, a marketing lesson from Sydney Sweeney on this week’s “Action Items.”

